HIGHLIGHTS
- who: Chung Ying Chan from the Oxford Institute for Radiation Oncology, Department of Oncology, University of Oxford, Old Road Campus Research Building, Off Roosevelt Drive, DQ Oxford, UK have published the research: Imaging PARP with [, in the Journal: (JOURNAL)
- what: The authors report the in vitro and in vivo evaluation of u00ad[18F]rucaparib in human pancreatic cancer models. Taken together the authors demonstrate the potential of u00ad[18F]rucaparib as a non-invasive PARP-targeting imaging agent for pancreatic cancers. This study shows the potential use of_[u00ad 18F]rucaparib or u00ad[18F] olaparib . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.